Company Filing History:
2 out of 338 
1 out of 789 
1 out of 1 Years Active: 2016-2022
Title: Alastair Compston: Innovator in Autoimmune Disease Treatment
Introduction
Alastair Compston is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of medicine, particularly in the diagnosis and treatment of autoimmune diseases associated with multiple sclerosis. With a total of 3 patents to his name, Compston's work is paving the way for advancements in patient care.
Latest Patents
Compston's latest patents include innovative methods and compositions for diagnosing and treating autoimmune diseases secondary to multiple sclerosis. One of his notable inventions focuses on assessing genotypes associated with elevated IL-21 levels. This invention provides methods for diagnosing and treating multiple sclerosis (MS) patients, particularly those at increased risk of developing secondary autoimmune diseases following lymphocyte depletion. The methods include identifying specific single nucleotide polymorphism genotypes that indicate elevated IL-21 levels. Additionally, the patents embrace methods for selecting treatment regimens for MS patients and the reagents useful in these methods.
Career Highlights
Throughout his career, Alastair Compston has worked with notable organizations, including Cambridge Enterprise Limited and Genzyme Corporation. His experience in these companies has allowed him to collaborate with other experts in the field and further his research in autoimmune diseases.
Collaborations
Compston has collaborated with esteemed colleagues such as Alasdair J Coles and Joanne L Jones. These partnerships have contributed to the development of his innovative approaches to treating multiple sclerosis and related conditions.
Conclusion
Alastair Compston's work in the field of autoimmune disease treatment showcases his dedication to improving patient outcomes. His patents and collaborations highlight the importance of innovation in medical research.